Tag Archives: Actos
-
-
FDA Halts Enrollment in Clinical Trials While Weighing Avandia Recall
-
FDA Panel Does Not Recommend Avandia Recall, Despite Heart Risks
-
Avandia Heart Attack Study Data Concealed by Glaxo in 2001: FDA Reviewer
-
Side Effects of Avandia Have FDA Reviewers Split Before Key Meeting
-
Avandia Recall May be Recommended by FDA Panel Next Month
-
Problems with Avandia Continue to Mount for GlaxoSmithKline
-
Avandia Side Effects May Have Hurt or Killed 100,000 People: Draft Study
-
Avandia Heart Attack Concerns May Be Scaring Away Test Subjects
-
Avandia Problems Should Result in Stop of Clinical Trial: Consumer Group